(1 - 45 von 208
)
Front Row Series 2: Andy Beck on AIGenetic Engineering and Biotechnology News
www.genengnews.com
— In Part Two of this series on AI in Drug Discovery and Development, Andy Beck MD PhD, CEO and co-founder of Path AI, discusses the ...
Agilent and PathAI Partner to Deliver AI-Powered Assay ...Stockhouse
stockhouse.com
vor 2 Tagen — ... possible data outputs, including novel scoring schemes and fully quantitative cut-points,” said Andy Beck, co-founder and CEO of PathAI. › news › a...
Agilent, PathAI Forge Deal on Algorithm-Supported Assay ...Precision Oncology News
www.precisiononcologynews.com
vor 2 Tagen — ... all possible data outputs, including novel scoring schemes and fully quantitative cut-points," PathAI CEO Andy Beck said in a statement. › ...
Hormone Doses in Contraceptives Could Be Reduced by ...Technology Networks
www.technologynetworks.com
vor 1 Tag — ... possible data outputs, including novel scoring schemes and fully quantitative cut-points,” said Andy Beck, co-founder and CEO of PathAI. › ...
sortiert nach Relevanz / Datum